Evidence map›Paper›PMID 35011967›Full record

ArticleJournal of clinical medicine2021

ICU-Acquired Pneumonia Is Associated with Poor Health Post-COVID-19 Syndrome.

Ignacio Martin-Loeches, Anna Motos, Rosario Menéndez, Albert Gabarrús, Jessica González, Laia Fernández-Barat, Adrián Ceccato, Raquel Pérez-Arnal, Dario García-Gasulla, Ricard Ferrer and 43 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Comparison of Long COVID-19 Caused by Different SARS-CoV-2 Strains: A Systematic Review and Meta-Analysis.International journal of environmental research and public health · 2022
    Pooled it
  3. Article
  4. COVID-19: Some unresolved issues.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2022
    Review
  5. Review
  6. Review
  7. Review
  8. Observational
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

53 authors at 20 institutions in 2 countries.

Ignacio Martin-LoechesCIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-5834-4063
Anna MotosCIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, 28029 Madrid, Spain.
Rosario MenéndezCIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, 28029 Madrid, Spain.
Albert GabarrúsCIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, 28029 Madrid, Spain.
Jessica GonzálezTranslational Research in Respiratory Medicine Group (TRRM), Lleida Biomedical Research Institute (IRBLleida), 25198 Lleida, Spain.
Laia Fernández-BaratCIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, 28029 Madrid, Spain.ORCID 0000-0001-7528-9636
Adrián CeccatoCIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, 28029 Madrid, Spain.ORCID 0000-0001-9454-062X
Raquel Pérez-ArnalBarcelona Supercomputing Centre (BSC), 08034 Barcelona, Spain.ORCID 0000-0002-0041-8146
Dario García-GasullaBarcelona Supercomputing Centre (BSC), 08034 Barcelona, Spain.ORCID 0000-0001-6732-5641
Ricard FerrerCIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-4859-4747
Jordi RieraCIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, 28029 Madrid, Spain.
José Ángel LorenteCIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, 28029 Madrid, Spain.
Óscar PeñuelasCIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, 28029 Madrid, Spain.
Jesús F Bermejo-MartinCIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, 28029 Madrid, Spain.
David de Gonzalo-CalvoTranslational Research in Respiratory Medicine Group (TRRM), Lleida Biomedical Research Institute (IRBLleida), 25198 Lleida, Spain.
Alejandro RodríguezCritical Care Department, Hospital Joan XXIII, 43005 Tarragona, Spain.
Ferran BarbéTranslational Research in Respiratory Medicine Group (TRRM), Lleida Biomedical Research Institute (IRBLleida), 25198 Lleida, Spain.
Luciano AguileraAnestesia, Reanimación y Terapia del Dolor, Hospital Universitario de Basurto, 48013 Bilbao, Spain.
Rosario Amaya-VillarIntensive Care Clinical Unit, Hospital Universitario Virgen de Rocío, 41013 Sevilla, Spain.
Carme BarberàHospital Santa Maria, IRBLleida, 25198 Lleida, Spain.
José BarberánCritical Care Department, Hospital Universitario HM Montepríncipe, Universidad San Pablo-CEU, 28660 Madrid, Spain.
Aaron Blandino OrtizServicio de Medicina Intensiva, Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain.ORCID 0000-0002-3184-6418
Elena Bustamante-MunguiraDepartment of Intensive Care Medicine, Hospital Clínico Universitario Valladolid, 47003 Valladolid, Spain.
Jesús CaballeroCritical Care Department, Hospital Universitari Arnau de Vilanova, IRBLleida, 25198 Lleida, Spain.
Cristina CarbajalesHospital Álvaro Cunqueiro, 36213 Vigo, Spain.ORCID 0000-0002-4496-5336
Nieves CarbonellIntensive Care Unit, Hospital Clínico y Universitario de Valencia, 46010 Valencia, Spain.ORCID 0000-0002-9149-0310
Mercedes Catalán-GonzálezDepartment of Intensive Care Medicine, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Cristóbal GalbánDepartment of Medicine, CHUS, Complejo Hospitalario Universitario de Santiago, 15076 Santiago de Compostela, Spain.
Víctor D Gumucio-SanguinoDepartment of Intensive Care, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
Maria Del Carmen de la TorreHospital de Mataró de Barcelona, 08301 Mataró, Spain.
Emili DíazDepartment of Medicine, Universitat Autònoma de Barcelona (UAB), Critical Care Department, Corpo-Ració Sanitària Parc Taulí, Sabadell, 08208 Barcelona, Spain.ORCID 0000-0003-3637-3821
Elena GallegoUnidad de Cuidados Intensivos, Hospital San Pedro de Alcántara, 10003 Cáceres, Spain.
José Luis García GarmendiaIntensive Care Unit, Hospital San Juan de Dios del Aljarafe, 41930 Sevilla, Spain.ORCID 0000-0003-1443-9236
José Garnacho-MonteroIntensive Care Clinical Unit, Hospital Universitario Virgen Macarena, 41009 Seville, Spain.ORCID 0000-0003-2542-7601
José M GómezHospital General Universitario Gregorio Marañón, 28009 Madrid, Spain.
Ruth Noemí Jorge GarcíaIntensive Care Department, Hospital Nuestra Señora de Gracia, 50009 Zaragoza, Spain.
Ana Loza-VázquezUnidad de Medicina Intensiva, Hospital Universitario Virgen de Valme, 41014 Sevilla, Spain.
Judith Marín-CorralCritical Care Department, Hospital del Mar-IMIM, 08003 Barcelona, Spain.
Amalia Martínez de la GándaraDepartment of Intensive Medicine, Hospital Universitario Infanta Leonor, 28031 Madrid, Spain.
Ignacio Martínez VarelaCritical Care Department, Hospital Universitario Lucus Augusti, 27003 Lugo, Spain.
Juan Lopez MessaCritical Care Department, Complejo Asistencial Universitario de Palencia, 34005 Palencia, Spain.
Guillermo M AlbaicetaDepartamento de Biología Funcional, Instituto Universitario de Oncología del Principado de Asturias, Universidad de Oviedo, 33011 Oviedo, Spain.
Mariana Andrea NovoServei de Medicina Intensiva, Hospital Universitari Son Espases, Palma de Mallorca, 07120 Illes Balears, Spain.
Yhivian PeñascoServicio de Medicina Intensiva, Hospital Universitario Marqués de Valdecilla, 39008 Santander, Spain.
Pilar RicartServei de Medicina Intensiva, Hospital Universitari Germans Trias, 08916 Badalona, Spain.
Luis Urrelo-CerrónHospital Verge de la Cinta, 08916 Tortosa, Spain.
Angel Sánchez-MirallesHospital de Sant Joan d'Alacant, 03550 Alacant, Spain.
Susana Sancho ChinestaServicio de Medicina Intensiva, Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain.
Lorenzo SociasIntensive Care Unit, Hospital Son Llàtzer, Palma de Mallorca, 07198 Illes Balears, Spain.
Jordi Solé-ViolanCIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-0483-4470
Luis Tamayo LomasCritical Care Department, Hospital Universitario Río Hortega de Valladolid, 47102 Valladolid, Spain.
Pablo VidalIntensive Care Unit, Complexo Hospitalario Universitario de Ourense, 32005 Ourense, Spain.ORCID 0000-0003-0225-9975
Antoni TorresCIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-8643-2167
Instituto de Salud Carlos III · ESHospital Universitari Arnau de Vilanova · ESBarcelona Supercomputing Center · ESBellvitge University Hospital · ESComplejo Asistencial Universitario de Palencia · ESComplejo Hospitalario Universitario de Santiago · ESComplexo Hospitalario Universitario A Coruña · ESHospital Clínico Universitario de Valencia · ESHospital Clínico Universitario de Valladolid · ESHospital de Basurto · ESHospital Del Mar · ESHospital de Mataró · ESHospital General Universitario Gregorio Marañón · ESHospital Nuestra Señora de Alarcos · ESHospital San Pedro de Alcántara · ESHospital Son Llatzer · ESHospital Universitari de Santa Maria · ESHospital Universitari de Tortosa Verge de la Cinta · ESHospital Universitari Germans Trias i Pujol · ESHospital Universitari i Politècnic La Fe · ES

Funding

Centro de Investigación Biomédica en Red de Enfermedades Respiratorias COV20/00110,ISCIII
6 · The paper itself

Abstract

backgroundSome patients previously presenting with COVID-19 have been reported to develop persistent COVID-19 symptoms. While this information has been adequately recognised and extensively published with respect to non-critically ill patients, less is known about the incidence and factors associated with the characteristics of persistent COVID-19. On the other hand, these patients very often have intensive care unit-acquired pneumonia (ICUAP). A second infectious hit after COVID increases the length of ICU stay and mechanical ventilation and could have an influence on poor health post-COVID 19 syndrome in ICU-discharged patients.

methodsThis prospective, multicentre, and observational study was carrid out across 40 selected ICUs in Spain. Consecutive patients with COVID-19 requiring ICU admission were recruited and evaluated three months after hospital discharge.

resultsA total of 1255 ICU patients were scheduled to be followed up at 3 months; however, the final cohort comprised 991 (78.9%) patients. A total of 315 patients developed ICUAP (97% of them had ventilated ICUAP). Patients requiring invasive mechanical ventilation had more persistent post-COVID-19 symptoms than those who did not require mechanical ventilation. Female sex, duration of ICU stay, development of ICUAP, and ARDS were independent factors for persistent poor health post-COVID-19.

conclusionsPersistent post-COVID-19 symptoms occurred in more than two-thirds of patients. Female sex, duration of ICU stay, development of ICUAP, and ARDS all comprised independent factors for persistent poor health post-COVID-19. Prevention of ICUAP could have beneficial effects in poor health post-COVID-19.

Indexed as

COVID-19CT abnormalitiesICUlung functionpost-COVIDSARS-CoV-2sequelae

Identifiers

PMID35011967
PMCPMC8746263
OpenAlexW4205980111

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.